Use of nanoparticles to deliver immunomodulatory oligonucleotides.

about

Immunological properties of gold nanoparticles Nanoparticle-allergen complexes for allergen immunotherapy.Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.

P2860

Q33578950-9FA4BA38-351E-4111-80F9-FFD8EB59FA6B Q33834985-6EF77349-6567-49B6-8C4F-149061EE5894 Q38680785-C6129450-DCC8-4C2D-98FC-B77896E4AB00

P2860

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

Item

http://www.wikidata.org/entity/Q36995537

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

@en

type

Item

label

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

@en

prefLabel

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

@en

P1476

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

@en

P2093

Dennis M Klinman

http://www.w3.org/2001/XMLSchema#string

Takeshi Shimosato

http://www.w3.org/2001/XMLSchema#string

P2860

For better or worse? Telomerase inhibition and cancer

Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle

Rapid translocation of nanoparticles from the lung airspaces to the body.

Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer.

CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine

Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors

CpG motifs in bacterial DNA trigger direct B-cell activation.

Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells

CpG motifs in bacterial DNA and their immune effects.

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

P304

631-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/WNAN.1382

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takashi Sato

P577

2015-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26663867

http://www.w3.org/2001/XMLSchema#string

P932

4903938

http://www.w3.org/2001/XMLSchema#string

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

about

P2860

P2860

Use of nanoparticles to deliver immunomodulatory oligonucleotides.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932